Sulphonamides.
D000380:Agranulocytosis / Q000139:chemically induced; D000741:Anemia, Aplastic / Q000139:chemically induced; D000743:Anemia, Hemolytic / Q000139:chemically induced; D003460:Crystallization; D004342:Drug Hypersensitivity; D004352:Drug Resistance, Microbial; D005493:Folic Acid Antagonists; D006801:Humans; D007408:Intestinal Absorption; D011485:Protein Binding; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced; D013411:Sulfadiazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use; D014556:Urine
D005493:Folic Acid Antagonists; D013449:Sulfonamides; D013411:Sulfadiazine